Efficacy of Oseltamivir in Reducing the Duration of Clinical Illness, Viral Shedding, and Transmissibility Reduction Within Households Among Participants in an Influenza Disease Burden Surveillance Cohort in Urban Dhaka, Bangladesh.
Phase of Trial: Phase III
Latest Information Update: 08 Jun 2018
At a glance
- Drugs Oseltamivir (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- 11 Jul 2011 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.
- 11 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Jul 2008 New trial record.